PT3157561T - Anticorpos contra alfa-v beta-8 melhorados - Google Patents
Anticorpos contra alfa-v beta-8 melhoradosInfo
- Publication number
- PT3157561T PT3157561T PT158096990T PT15809699T PT3157561T PT 3157561 T PT3157561 T PT 3157561T PT 158096990 T PT158096990 T PT 158096990T PT 15809699 T PT15809699 T PT 15809699T PT 3157561 T PT3157561 T PT 3157561T
- Authority
- PT
- Portugal
- Prior art keywords
- antibodies
- beta
- improved alpha
- alpha
- improved
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013114P | 2014-06-17 | 2014-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3157561T true PT3157561T (pt) | 2020-03-25 |
Family
ID=54936235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT158096990T PT3157561T (pt) | 2014-06-17 | 2015-06-17 | Anticorpos contra alfa-v beta-8 melhorados |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20170129955A1 (pt) |
| EP (1) | EP3157561B1 (pt) |
| JP (2) | JP2017522289A (pt) |
| CN (1) | CN107405396A (pt) |
| CY (1) | CY1123219T1 (pt) |
| DK (1) | DK3157561T3 (pt) |
| ES (1) | ES2779412T3 (pt) |
| HR (1) | HRP20200420T1 (pt) |
| HU (1) | HUE048663T2 (pt) |
| LT (1) | LT3157561T (pt) |
| ME (1) | ME03678B (pt) |
| PL (1) | PL3157561T3 (pt) |
| PT (1) | PT3157561T (pt) |
| RS (1) | RS60061B1 (pt) |
| SI (1) | SI3157561T1 (pt) |
| WO (1) | WO2015195835A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20211605A1 (es) * | 2018-09-07 | 2021-08-23 | Pfizer | ANTICUERPOS ANTI-avß8 Y COMPOSICIONES Y USOS DE LOS MISMOS |
| TW202140554A (zh) | 2020-01-27 | 2021-11-01 | 英商梅迪繆思有限公司 | 用於治療腎臟疾病之抗αｖβ８整聯蛋白抗體 |
| CN117126282B (zh) * | 2023-10-26 | 2024-01-12 | 迈威(上海)生物科技股份有限公司 | 抗体及其在制备阻断αvβ8与Latent TGF-β的结合的药物中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1991000360A1 (en) | 1989-06-29 | 1991-01-10 | Medarex, Inc. | Bispecific reagents for aids therapy |
| AU8295491A (en) | 1990-06-29 | 1992-01-23 | Biosource Technologies Incorporated | Melanin production by transformed microorganisms |
| ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| US7163681B2 (en) * | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
| US20050025763A1 (en) * | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
| SG10201912554TA (en) * | 2005-03-23 | 2020-02-27 | Genmab As | Antibodies against cd38 for treatment of multiple myeloma |
| EP2021029B1 (en) * | 2006-05-26 | 2014-06-11 | MacroGenics, Inc. | Humanized fc gamma riib-specific antibodies and methods of use thereof |
| SG183356A1 (en) | 2010-02-18 | 2012-09-27 | Univ California | INTEGRIN aVß8 NEUTRALIZING ANTIBODY |
| SG2014014237A (en) * | 2011-08-17 | 2014-07-30 | Univ California | Antibodies that bind integrin alpha-v beta-8 |
-
2015
- 2015-06-17 ME MEP-2020-57A patent/ME03678B/me unknown
- 2015-06-17 WO PCT/US2015/036284 patent/WO2015195835A2/en active Application Filing
- 2015-06-17 ES ES15809699T patent/ES2779412T3/es active Active
- 2015-06-17 EP EP15809699.0A patent/EP3157561B1/en active Active
- 2015-06-17 DK DK15809699.0T patent/DK3157561T3/da active
- 2015-06-17 US US15/319,147 patent/US20170129955A1/en not_active Abandoned
- 2015-06-17 CN CN201580044081.8A patent/CN107405396A/zh active Pending
- 2015-06-17 HU HUE15809699A patent/HUE048663T2/hu unknown
- 2015-06-17 RS RS20200311A patent/RS60061B1/sr unknown
- 2015-06-17 JP JP2016573732A patent/JP2017522289A/ja active Pending
- 2015-06-17 SI SI201531139T patent/SI3157561T1/sl unknown
- 2015-06-17 LT LTEP15809699.0T patent/LT3157561T/lt unknown
- 2015-06-17 PL PL15809699T patent/PL3157561T3/pl unknown
- 2015-06-17 PT PT158096990T patent/PT3157561T/pt unknown
-
2020
- 2020-03-16 HR HRP20200420TT patent/HRP20200420T1/hr unknown
- 2020-03-18 CY CY20201100249T patent/CY1123219T1/el unknown
- 2020-03-24 US US16/828,553 patent/US20200277381A1/en not_active Abandoned
- 2020-07-20 JP JP2020123886A patent/JP2020183425A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017522289A (ja) | 2017-08-10 |
| SI3157561T1 (sl) | 2020-08-31 |
| ME03678B (me) | 2020-10-20 |
| EP3157561A4 (en) | 2018-02-28 |
| ES2779412T3 (es) | 2020-08-17 |
| US20200277381A1 (en) | 2020-09-03 |
| HUE048663T2 (hu) | 2020-07-28 |
| WO2015195835A2 (en) | 2015-12-23 |
| WO2015195835A3 (en) | 2016-03-10 |
| JP2020183425A (ja) | 2020-11-12 |
| LT3157561T (lt) | 2020-07-10 |
| CN107405396A (zh) | 2017-11-28 |
| CY1123219T1 (el) | 2021-10-29 |
| EP3157561A2 (en) | 2017-04-26 |
| HRP20200420T1 (hr) | 2020-06-26 |
| US20170129955A1 (en) | 2017-05-11 |
| PL3157561T3 (pl) | 2020-06-29 |
| EP3157561B1 (en) | 2019-12-18 |
| RS60061B1 (sr) | 2020-04-30 |
| DK3157561T3 (da) | 2020-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250583A0 (en) | Anti-tigit antibodies | |
| IL252004A0 (en) | Ether-substituted antibody | |
| HK1217207A1 (zh) | 具有改善的藥物動力學的抗- 抗體 | |
| SG11201703403TA (en) | Anti-tim-3 antibodies | |
| SG11201703346PA (en) | Anti-tim-3 antibodies | |
| IL252422B (en) | Effector-deficient anti-cd32a antibodies | |
| IL291164A (en) | Anti-nme antibody | |
| IL250374A0 (en) | Antibodies against ceramide | |
| GB201410520D0 (en) | Antibody | |
| PT3178931T (pt) | Anticorpo anti-orai1 | |
| IL247988A0 (en) | Antibodies against hpa–1a | |
| LT3157561T (lt) | Patobulinti alfa-v beta-8 antikūnai | |
| GB201419092D0 (en) | Anti-TIM-3 antibodies | |
| GB201419089D0 (en) | Anti-TIM-3 antibodies | |
| GB201417614D0 (en) | Antibodies | |
| GB201414270D0 (en) | Antibodies | |
| GB201405775D0 (en) | Antibodies | |
| GB201401200D0 (en) | Antibodies | |
| GB201418776D0 (en) | Antibody | |
| GB201413745D0 (en) | Antibody | |
| GB201411319D0 (en) | Antibody | |
| GB201407535D0 (en) | Antibody Drug - Conjugates |